More about

Inflammation

News
September 19, 2024
4 min read
Save

Most patients stick with at-home FeNO measurement regimen

Most patients stick with at-home FeNO measurement regimen

Patients with different asthma severity regularly used a home device for measuring fractional exhaled nitric oxide for 12 weeks as part of their asthma management strategies, according to a poster presentation here.

News
September 18, 2024
2 min read
Save

BODE index score does not change dupilumab efficacy in COPD with type 2 inflammation

BODE index score does not change dupilumab efficacy in COPD with type 2 inflammation

Dupilumab’s impact on exacerbation rate and lung function in adults with COPD and type 2 inflammation did not differ based on BODE index score, according to a poster presented at the European Respiratory Society International Congress.

News
September 16, 2024
3 min read
Save

Inflammation, mucus plugging improve by 4 weeks with dupilumab

Inflammation, mucus plugging improve by 4 weeks with dupilumab

Patients with asthma on dupilumab saw reduced airway inflammation and mucus plugging beginning at 4 weeks with steady improvements through 24 weeks, according to a study presented at the European Respiratory Society International Congress.

News
September 12, 2024
2 min read
Save

Dupilumab lowers symptom burden in COPD, type 2 inflammation

Dupilumab lowers symptom burden in COPD, type 2 inflammation

At 52 weeks, adults with moderate/severe COPD and type 2 inflammation receiving dupilumab vs. placebo showed more improved symptom scores, according to a poster presented at the European Respiratory Society International Congress.

News
September 10, 2024
2 min read
Save

Researchers validate clinical scale for early catheter infection detection in hemodialysis

Researchers validate clinical scale for early catheter infection detection in hemodialysis

A clinical scale was validated for early detection of infections at the exit site of central venous catheters for hemodialysis in patients with kidney disease, according to a study.

News
September 10, 2024
3 min read
Save

Pooled BOREAS, NOTUS analysis: Dupilumab beneficial in COPD with type 2 inflammation

Pooled BOREAS, NOTUS analysis: Dupilumab beneficial in COPD with type 2 inflammation

Dupilumab led to improvement and was safe in adults with moderate to severe COPD and type 2 inflammation at week 52, according to a pooled analysis of BOREAS and NOTUS presented at the European Respiratory Society International Congress.

News
September 07, 2024
2 min read
Save

Fish oil supplementation, maternal genotype linked with childhood atopic dermatitis

Fish oil supplementation, maternal genotype linked with childhood atopic dermatitis

Fish oil supplementation during pregnancy was associated with children having a lower or higher risk for developing atopic dermatitis depending on the mother’s genotype, according to a study.

News
September 03, 2024
1 min read
Save

Corneal neuropathic pain management may require a multidisciplinary approach

Corneal neuropathic pain management may require a multidisciplinary approach

Diagnosis and treatment of corneal neuropathic pain may require a multidisciplinary approach, including comprehensive ocular assessment as well as medical and mental health history examinations, according to a report published in Eye.

News
August 27, 2024
1 min read
Save

Enrollment, dosing complete in phase 1 trial of AIV007 for AMD, diabetic macular edema

Enrollment, dosing complete in phase 1 trial of AIV007 for AMD, diabetic macular edema

AiViva Biopharma announced that it has completed enrollment and dosing of the last patient in a phase 1 clinical trial of AIV007 for wet age-related macular degeneration and diabetic macular edema.

News
August 22, 2024
2 min read
Save

Vegan diet better for weight loss than Mediterranean diet

Vegan diet better for weight loss than Mediterranean diet

A low-fat vegan diet significantly reduced harmful inflammatory dietary compounds compared with a Mediterranean diet, according to findings from a randomized study.

View more